The civic record
Read. Follow. Verify.1971 Senate Hearings on the National Sickle Cell Anemia Prevention Act
Record date · July 20, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
This document contains the official transcript of Senate hearings held on November 11 and 12, 1971, regarding , a proposed bill to establish a national program for the prevention and treatment of sickle cell anemia.
The hearings represent the legislative foundation for federal funding and research initiatives specifically targeting sickle cell anemia, which directly impacted the allocation of government resources for genetic disease screening and patient care.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Medical research community
The legislation proposed in the hearings would determine the scope and funding of federal research into sickle cell anemia.
Patients with sickle cell anemia
The proposed act aimed to establish national programs for the prevention and treatment of the condition.
Key Facts
- The hearings were conducted by the Subcommittee on Health of the Committee on Labor and Public Welfare.
- The subject of the hearings was the review of S. 2676, the National Sickle Cell Anemia Prevention Act.
- The hearings took place over two days: November 11 and 12, 1971.
- The purpose of the legislation was to create a national framework for preventing and treating sickle cell anemia.
Frequently Asked Questions
What was the purpose of these hearings?
When did these hearings take place?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Federalization of Genetic Disease Research
The hearings mark a specific point in 1971 where the federal government moved to centralize the response to a specific genetic condition through dedicated legislation.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance80How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz5Current news / social attention level
Publisher tools
